RESEARCH INTERESTS

· Evaluation of the biological behavior of compounds radiolabeled with gamma-, beta- or positron emitters, as possible radiopharmaceuticals

·  Design, synthesis and pharmacological evaluation of the in vivo behavior of novel biomolecules

·  Design, synthesis and evaluation of a series of novel antiepileptic compounds.

CURRENT RESEARCH FUNDING PROGRAMMES (as main investigator)

EMPEIRIKEION INSTITUTE, “Synthesis, characterization and biological evaluation of novel radioiodinized tracers for the imaging of multidrug resistance in pathological tumor models”

CURRENT RESEARCH FUNDING PROGRAMMES (as participant)

ARISTEIA II, DETEGAR, “Development of multimodal imaging agents for Sentinel Node Detection and Cancer Diagnosis”